LQT3: who is at risk for sudden cardiac death?
Eckardt
Lars
L
Medizinische Klinik und Poliklinik C, Universitätsklinikum Münster, Münster, Germany. l.eckardt@uni-muenster.de
D000328:Adult; D004247:DNA / Q000235:genetics; D016757:Death, Sudden, Cardiac / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation*; D004562:Electrocardiography; D005260:Female; D005838:Genotype; D006801:Humans; D015994:Incidence; D008133:Long QT Syndrome / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D008297:Male; D009124:Muscle Proteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D062554:NAV1.5 Voltage-Gated Sodium Channel; D012307:Risk Factors; D015222:Sodium Channels / Q000235:genetics / Q000378:metabolism
D009124:Muscle Proteins; D062554:NAV1.5 Voltage-Gated Sodium Channel; C568320:SCN5A protein, human; D015222:Sodium Channels; D004247:DNA